A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

NCT04464759 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Nivolumab
DRUG: Hydroxychloroquine
DRUG: Ipilimumab

Sponsor

Ravi Amaravadi, MD

Collaborators

[object Object]